New study aims to predict fracture risk in bone cancer patients

NCT ID NCT06524843

Recruiting now Knowledge-focused Sponsor: Costantino Errani Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

Researchers are gathering medical records, scans, and lab results from 250 patients with bone metastases that spread from other cancers. They will use this data to create a dataset called RAW, which will help develop computer models to predict fracture risk and life expectancy. The study does not test any new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better tools for doctors to predict fracture risk and life expectancy in patients with bone metastases.
What could go wrong: This is an observational study that only collects existing data, so it won't directly test a new treatment. The models may not work as hoped in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic carcinoma in the bone

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE METASTASES

Contacts and locations

Locations

IRCCS Istituto Ortopedico Rizzoli
RECRUITING

Bologna, Emilia-Romagna, 40134, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.